This inventor holds 1 USPTO granted patent. Top assignee: Digmbio. Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Tae-Sung Koo: Innovator in Pharmaceutical Composition
Introduction
Tae-Sung Koo is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications.
Latest Patents
Tae-Sung Koo holds a patent for isoquinolinone derivatives, which includes a method for preparing these compounds and a pharmaceutical composition aimed at preventing or treating poly(ADP-ribose) polymerase-1 (PARP-1)-related diseases. The invention highlights the isoquinolinone derivatives' exceptional PARP-1 inhibitory effect at nanomolar concentrations. Additionally, these derivatives demonstrate a remarkable cytoprotective effect, particularly in treating ophthalmic diseases or disorders, such as retinal disorders.
Career Highlights
Koo is currently associated with Digmbio, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Tae-Sung Koo collaborates with talented individuals in his field, including coworkers Eunhee Kim and Sehwan Oh. Their combined expertise contributes to the innovative projects at Digmbio, Inc.
Conclusion
Tae-Sung Koo's contributions to the pharmaceutical industry through his innovative patent on isoquinolinone derivatives exemplify the potential of targeted therapies in treating complex diseases. His ongoing work at Digmbio, Inc. continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile